BerkovicSFDuncanJSBarkovichA: ILAE Commission neuroimaging recommendations for neuroimaging of patients with epilepsy. Epilepsia38: 1–2, 1997.
2.
BerkovicSFDuncanJSBarkovichA: (1998) ILAE Neuroimaging commission recommendations for neuroimaging of persons with refractory epilepsy. Epilepsia39: 1375–1376, 1998.
3.
DuncanJSAliRBarkovichJ: ILAE Commission on diagnostic strategies: Recommendations for functional neuroimaging of persons with epilepsy. Epilepsia41: 1350–1356, 2000.
4.
BerginPSFishDRShorvonSD: Magnetic resonance imaging in partial epilepsy: Additional abnormalities shown with the fluid attenuated inversion recovery (FLAIR) pulse sequence. J Neurol Neurosurg Psychiatry58: 439–443, 1995.
5.
WieshmannUCFreeSEverittA: Mr imaging with a fast flair sequence. J Neurol Neurosurg Psychiatry61: 357–361, 1996.
6.
WieshmannUC: Clinical application of neuroimaging in epilepsy. J Neurol Neurosurg Psychiatry74: 466–470, 2003.
7.
Von OertzenJUrbachHJungbluthS: Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy. J Neurol Neurosurg Psychiatry73: 643–647, 2002.
8.
JacksonGDBerkovicSFTressBM: Hippocampal sclerosis can be reliably detected by magnetic resonance imaging. Neurology40: 1869–1875, 1990.
9.
JacksonGDBerkovicSFDuncanJS: Optimizing the diagnosis of hippocampal sclerosis using MR imaging. Am J Neuroradiol14: 753–762, 1993.
10.
MeinersLCVan GilsAJansenGH: Temporal Lobe Epilepsy: The Various MR appearances of histologically proven mesial temporal sclerosis. Am J Neuroradiol15: 1547–1555, 1994.
11.
MoranNFLemieuxLKitchenND: Extrahippocampal temporal lobe atrophy in temporal lobe epilepsy and mesial temporal sclerosis. Brain124, 167–175, 2001.
12.
JutilaLYlinenAPartanenK: Mr Volumetry of the entorhinal, perirhinal, and temporopolar cortices in drug-refractory temporal lobe epilepsy. Am J Neuroradiol22: 1490–1501, 2001.
13.
BernasconiNBernasconiACaramanosZ: Mesial temporal damage in temporal lobe epilepsy: A volumetric MRI study of the hippocampus, amygdala and parahippocampal region. Brain126: 462–469, 2003.
14.
BernasconiNBernasconiACaramanosZ: Entorhinal cortex atrophy in epilepsy patients exhibiting normal hippocampal volumes. Neurology56: 1335–1139, 2001.
15.
CookMJFishDRShorvonSD: Hippocampal volumetric and morphometric studies in frontal and temporal lobe epilepsy. Brain115: 1001–1015, 1992.
16.
Van PaesschenWSisodiyaSConnellyA: Quantitative hippocampal MRI and intractable temporal lobe epilepsy. Neurology45: 2233–2240, 1995.
17.
WoermannFGBarkerGJBirnieKD: Regional changes in hippocampal T2-relaxation time – A quantitative magnetic resonance imaging study of hippocampal sclerosis. J Neurol Neurosurg Psychiatry65: 656–664, 1998.
18.
WoermannFGSteinerHBarkerGJ: A fast FLAIR dual-echo technique for hippocampal T2 relaxometry: First experiences in patients with temporal lobe epilepsy. J Mag Res Imaging13(4), 547–552, 2001.
19.
Van PaesschenWConnellyAJacksonGD: The Spectrum of hippocampal Sclerosis. A quantitative MRI Study. Ann Neurol41: 41–51, 1997.
20.
BartlettPARichardsonMPDuncanJS: Measurement of amygdala T2 relaxation time in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry73: 753–755, 2002.
21.
RaymondAAHalpinSFAlsanjariN: Dysembryoplastic Neuroepithelial Tumor. Features In 16 Patients. Brain117: 461–475, 1994.
22.
BerkovicSFAndermannFMelansonD: Hypothalamic hamartomas and ictal laughter: Evolution of a characteristic epileptic syndrome and diagnostic value of magnetic resonance imaging. Ann Neurol23: 429–439, 1988.
23.
UrbachHSchefflerBHeinrichsmeierT: Focal cortical dysplasia of taylor's balloon cell type: A clinico pathological entity with characteristic neuroimaging and histopathological features, and favorable postsurgical outcome. Epilepsia43: 33–40, 2002.
24.
BernasconiAAntelSBCollinsDL: Texture analysis and morphological processing of magnetic resonance imaging assist detection of focal cortical dysplasia in extra-temporal partial epilepsy. Ann Neurol49: 770–775, 2001.
25.
SancheteePCVenkataramanCSDhamijaRM: Epilepsy as a manifestation of neurocysticercosis. J Assoc Physicians India39: 325–328, 1991.
26.
BriellmannRSBerkovicSFSyngeniotisA: Seizure-sssociated hippocampal volume loss: A longitudinal magnetic resonance study of temporal lobe epilepsy. Ann Neurol51: 641–644, 2002.
27.
FuerstDShahJShahA: Hippocampal sclerosis is a progressive disorder: A longitudinal volumetric MRI study. Ann Neurol53: 413–416, 2003.
28.
LiuRSNLemieuxLBellGS: The Structural consequences of newly diagnosed seizures. Ann Neurol52: 573–580, 2002.
29.
LiuRSNLemieuxLBellGS: Progressive Neocortical Damage In Epilepsy. Ann Neurol53: 321–324, 2003.
30.
WieshmannUCSymmsMRShorvonSD: Diffusion Changes In Status Epilepticus. Lancet350: 493–494, 1997.
31.
ErikssonSHSymmsMRRugg-GunnFJ: Diffusion tensor imaging in patients with epilepsy and malformations of cortical development. Brain124: 617–626, 2001.
32.
Rugg-GunnFJErikssonSHSymmsMR: Diffusion tensor imaging of Cryptogenic and acquired partial epilepsies. Brain124: 627–636, 2001.
33.
ErikssonSHSymmsMRRugg-GunnFJ: Exploring white matter tracts in band heterotopia using diffusion tractography. Ann Neurol52: 327–334, 2002.
34.
Rugg-GunnFJErikssonSHBoulbyPA: Magnetization transfer imaging in focal epilepsy. Neurology60: 1638–1645, 2003.
35.
ErikssonSHStepneyASymmsMR: Ultra-Fast Low-Angle Rapid Acquisition and relaxation enhancement (UFLARE) in patients with epilepsy. Neuroradiology43: 1040–1045, 2001.
36.
WolfRLAlsopDCLevy-ReisI: Detection of mesial temporal lobe hypoperfusion in patients with temporal lobe epilepsy by use of arterial spin labeled perfusion MR imaging. Am J Neuroradiol22: 1334–1341, 2001.
37.
WoermannFGFreeSLKoeppMJ: Voxel-by-voxel comparison of automatically segmented cerebral grey matter - A rater-independent comparison of structural MRI in patients with epilepsy. Neuroimage10: 373–384, 1999.
38.
HammersAKoeppMJFreeSL: Implementation and application of a brain template for multiple volumes of interest. Human Brain Mapping15: 165–174, 2002.
39.
PitiotATogaAWThompsonPM: Adaptive elastic segmentation of brain MRI via shape-model-guided evolutionary programming. IEEE Trans Med Imaging21: 910–923, 2002.
40.
MeinersLCScheffersJMDe KortGA: Curved reconstructions versus three-dimensional surface rendering in the demonstration of cortical lesions in patients with extratemporal epilepsy. Invest Radiol136(4), 225–233, 2001.
41.
WinklerPAVollmarCKrishnanKG: Usefulness of 3-D reconstructed images of the human cerebral cortex for localization of subdural electrodes in epilepsy surgery. Epilepsy Res41: 169–178, 2000.
42.
KrakowKWieshmannUCWoermannFG: Multimodal MR imaging: Functional, diffusion, tensor and chemical shift imaging in a patient with localisation-related epilepsy. Epilepsia40: 1459–1462, 1999.
43.
KrakowKWoermannFGSymmsMR: EEG-triggered functional MRI of interictal epileptiform activity in patients with partial seizures. Brain122: 1679–1688, 1999.
44.
SymmsMRAllenPJWoermannFG: Reproducible localisation of interictal epileptiform activity using functional MRI. Phys Med Biol41: 161–168, 1999.
45.
LemieuxLKrakowKFishDR: Comparison of spike-triggered functional MRI BOLD activation and EEG dipole model localization. Neuroimage14: 1097–1104, 2001.
46.
LemieuxLSalek-HaddadiAJosephsO: Event-related FMRI with aimultaneous and continuous EEG: Description of the method and initial case report. Neuroimage14: 780–787, 2001.
47.
HeilbrunMPLeeJNAlvordL: Practical application of FMRI for surgical planning. Stereotact Funct Neurosurg76: 168–174, 2001.
48.
NelsonLLapsiwalaSHaughtonVM: Preoperative mapping of the supplementary motor area in patients harboring tumors in the medial frontal kobe. J Neurosurg97: 1108–1114, 2002.
49.
GaillardWDBalsamoLXuB: Language dominance in partial epilepsy patients identified with an FMRI reading task. Neurology59: 256–265, 2002.
50.
BinderJRSwansonSJHammekeTA: Determination of language dominance using functional MRI: A comparison with the Wada test. Neurology46: 978–984, 1996.
51.
BensonRRFitzgeraldDBLesueurLL: Language dominance determined by whole brain functional MRI in patients with brain lesions. Neurology52: 798–809, 1999.
52.
AdcockJEWiseRGOxburyJM: Quantitative FMRI assessment of the differences in lateralization of language-related brain activation in patients with temporal lobe epilepsy. Neuroimage18: 423–438, 2003.
53.
WorthingtonCVincentDJBryantAE: Comparison of functional magnetic resonance imaging for language localization and intracarotid speech amytal testing in presurgical evaluation for intractable epilepsy. Preliminary results. Stereotact Funct Neurosurg69: 197–201, 1997.
54.
RuttenGKRamseyNFVan RijenPC: FMRI-determined language lateralization in patients with unilateral or mixed language dominance according to the Wada test. Neuroimage17: 447–460, 2002.
55.
JayakarPBernalBSantiagoMedina L: False lateralization of language cortex on functional MRI after a cluster of focal seizures. Neurology58: 490–492, 2002.
56.
CarpentierAPughKRWesterveldM: Functional MRI of language processing: Dependence on input modality and temporal lobe epilepsy. Epilepsia42: 1241–1254, 2001.
57.
GaillardWdPuglieseMCbGrandin, Cortical Localization Of Reading In Normal Children: An Fmri Language Study. Neurology57(1), 47–54, 2001.
58.
RuttenGJRamseyNFVan RijenPC: Development of a functional magnetic resonance imaging protocol for intraoperative localization of critical temporoparietal language areas. Ann Neurol51: 350–360, 2002.
59.
SternCECorkinSGonzalezRG: The hippocampal formation participates in novel picture encoding: Evidence from functional magnetic resonance imaging. Proc Nat Acad Sci Usa93: 8660–8665, 1996.
60.
GabrieliJDEBrewerJBDesmondJE: Separate neural bases of two fundamental memory processes in human medial temporal lobe. Science276: 264–266, 1997.
61.
FernandezGWeyertsHSchrader-BolscheM: Successful verbal encoding into episodic memory engages the posterior hippocampus: A parametrically analyzed functional magnetic resonance resonance imaging study. J Neurosci18: 1841–1847, 1998.
DupontSSamsonYVan De MoortelePF: Delayed verbal memory retrieval: A functional MRI study in epileptic patients with structural lesions of the left medial temporal lobe. Neuroimage14: 995–1003, 2001.
64.
ConnellyAJacksonGDDuncanJS: Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology44: 1411–1417, 1994.
65.
WoermannFGMacleanMABartlettPA: Short echo time single voxel MRS of hippocampal sclerosis and temporal lobe epilepsy. Ann Neurol45: 369–375, 1999.
66.
KnowltonRCLaxerKDEndeG: Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy. Ann Neurol42: 829–837, 1997.
67.
ConnellyAVan PaesschenWPorterDA: Proton magnetic resonance spectroscopy in MRI-negative temporal lobe epilepsy. Neurology51: 61–66, 1998.
68.
SimisterRJWoermannFGMcLeanMA: A short-echo-time proton magnetic resonance spectroscopic imaging study of temporal lobe epilepsy. Epilepsia43: 1021–1031, 2003.
GarciaPALaxerKDVan Der GrondJ: Correlation if seizure frequency with N-acetyl-aspartate levels determined by 1H magnetic resonance spectroscopic imaging. Mag Res Imaging15: 475–478, 1997.
74.
KuznieckyRHetheringtonHPanJ: Proton spectroscopic imaging at 4.1 tesla in patients with malformations of cortical development and Epilepsy. Neurology48: 1018–1024, 1997.
75.
WoermannFGMcLeanMABartlettPA: Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy. Brain124: 427–436, 2001.
76.
NgTComairYGXueM: Temporal lobe epilepsy: Presurgical localization with proton chemical shift imaging. Radiology193: 465–472, 1994.
77.
CendesFStanleyJADubeauF: Proton magnetic resonance spectroscopic imaging for discrimination of absence and complex partial seizures. Ann Neurology41: 74–81, 1997.
78.
NgTComairYGXueM: Temporal lobe epilepsy: Presurgical localization with proton chemical shift imaging. Radiology193: 465–472, 1994.
79.
CendesFStanleyJADubeauF: Proton magnetic resonance spectroscopic imaging for discrimination of absence and complex partial seizures. Ann Neurol41: 74–81, 1997.
80.
LazeyrasFBlankeOZimineI: MRI, (1)H-Mrs, and functional MRI during and after prolonged nonconvulsive seizure activity. Neurology55: 1677–1682, 2000.
81.
MuellerSGKolliasSSTrabesingerAH: Proton magnetic resonance spectroscopy characteristics of a focal cortical dysgenesis during status epilepticus and in the interictal state. Seizure10: 518–524, 2001.
82.
PetroffOACRothmanDLBeharKL: Initial Observations on the effect of vigabatrin on in vivo 1H spectroscopic measurements of Gaba, glutamate and glutamine in human brain. Epilepsia36: 457–464, 1995.
83.
PetroffOACRothmanDLBeharKL: The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann Neurol39: 95–99, 1996.
PetroffOACRothmanDLBeharKL: Low brain gaba level is associated with poor seizure control. Ann Neurol40: 908–911, 1996.
86.
PetroffOAHyderFRothmanDL: Homocarnosine and seizure control in juvenile myoclonic epilepsy and complex partial seizures. Neurology56: 709–715, 2001.
87.
LoscherW: Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy. Prog Neurobiol54: 721–741, 1998.
88.
ChoiCGFrahmJ: Localized proton MRS of the human hippocampus: Metabolite concentrations and relaxation times. Mag Res Med41: 204–207, 1999.
89.
FazekasFKapellerPSchmidtR: Magnetic resonance imaging and spectroscopy findings after focal status epilepticus. Epilepsia36: 946–949, 1995.
90.
GrunwaldFMenzelCPavicsL: Ictal and interictal brain SPECT imaging in epilepsy using technetium-99m-ECD. J Nucl Med35, 1896–1901, 1994.
91.
RoweCCBerkovicSFAustinMC: Visual and quantitative analysis of interictal spect with technetium-99m-HMPAO in temporal lobe epilepsy. J Nucl Med32: 1688–1694, 1991.
92.
MarksDAKatzAHofferP: Localization of extratemporal epileptic foci during ictal single photon emission computed tomography. Ann Neurol31: 250–255, 1992.
93.
DasheiffRM: A review of interictal cerebral blood flow in the evaluation of patients for epilepsy surgery. Seizure1: 117–125, 1992.
94.
DevousMD SRThistedRAMorganGF: Spect brain imaging in epilepsy: A meta-analysis. J Nucl Med39: 285–293, 1998.
95.
NewtonMRBerkovicSFAustinMC: Dystonia, clinical lateralization, and regional blood flow changes in temporal lobe seizures. Neurology42: 371–377, 1992.
96.
NewtonMRBerkovicSFAustinMC: A postictal switch in blood flow distribution and temporal lobe seizures. J Neurol Neurosurg Psychiatry55: 891–894, 1992.
97.
HarveyASHopkinsIJBoweJM: Frontal lobe epilepsy: Clinical seizure characteristics and localization with ictal 99mTc-HMPAO SPECT. Neurology43: 1966–1980, 1993.
98.
HaymanMSchefferIEChinvarunY: Autosomal dominant nocturnal frontal lobe epilepsy: Demonstration of focal frontal onset and intrafamilial variation. Neurology49: 969–975, 1997.
99.
HoganRECookMJBinnsDW: Perfusion patterns in postictal 99mtc-HMPAO SPECT after coregistration with MRI in patients with mesial temporal lobe epilepsy. J Neurol Neurosurg Psychiatry63: 235–239, 1997.
100.
ZubalIGSpencerSSImamK: Difference Images Calculated From Ictal And Interictal Technetium-99m-HMPAO SPECT scans of epilepsy. J Nucl Med36: 684–689, 1995.
101.
O'brienTJSoELMullanBP: Subtraction spect co-registered to MRI improves postictal SPECT localization of seizure foci. Neurology52: 137–146, 1999.
102.
KaminskaAChironCVilleD: Ictal spect in children with epilepsy: Comparison with intracranial EEG and relation to postsurgical outcome. Brain126: 248–260, 2003.
103.
LancmanMEMorrisHH3rdRajaS: Usefulness of Ictal and interictal 99m Tc ethyl cysteinate dimer single photon emission computed tomography in patients with refractory partial epilepsy. Epilepsia38: 466–471, 1997.
104.
SepkutyJPLesserRPCivelekCA: An automated injection system (with patient selection) for SPECT imaging in seizure localization. Epilepsia39: 1350–1356, 1998.
105.
Van PaesschenWDupontPVan HeerdenB: Self-injection ictal SPECT during partial seizures. Neurology54: 1994–1997, 2000.
106.
SignoriniMPaulesuEFristonK: Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping. Neuroimage9: 63–80, 1999.
107.
SavicIIngvarMStone-ElanderS: Comparison of [11C]flumazenil and [18F]FDG as pet markers of epileptic foci. J Neurol Neurosurg Psychiatry56: 615–621, 1993.
108.
HenryTRFreyKASackellaresJC: In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology43: 1998–2006, 1993.
109.
JuhaszCChuganiDCMuzikO: Relationship of flumazenil and glucose pet abnormalities to neocortical epilepsy surgery outcome. Neurology56: 1650–1658, 2001.
110.
TheodoreWH: When is positron emission tomography really necessary in epilepsy diagnosis?Curr Opin Neurol15: 191–195, 2002.
111.
GaillardWDBhatiaSBookheimerSY: FDG-PET and volumetric Mri in the evaluation of patients with partial epilepsy. Neurology45: 123–126, 1995.
112.
CheeMWMorrisHH3rdAntarMA: Presurgical evaluation of temporal lobe epilepsy using interictal temporal spikes and positron emission tomography. Arch Neurol50: 45–48, 1993.
113.
BlumDEEhsanTDunganD: Bilateral temporal hypometabolism in epilepsy. Epilepsia39: 651–659, 1998.
114.
HajekMAntoniniALeendersKL: Mesiobasal versus lateral temporal lobe epilepsy: Metabolic differences in the temporal lobe shown By interictal 18F-FDG positron emission tomography. Neurology43: 79–86, 1993.
115.
BouilleretVDupontSSpelleL: Insular cortex involvement in mesiotemporal lobe epilepsy: A positron emission tomography study. Ann Neurol51: 202–208, 2002.
116.
LamusuoSJutilaLYlinenA: [18F]FDG-PET Reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage. Arch Neurol58: 933–939, 2001.
117.
KnowltonRCLaxerKDKleinG: In vivo hippocampal glucose metabolism in mesial temporal lobe epilepsy. Neurology57: 1184–1190, 2001.
118.
GaillardWDKopylevLWeinsteinS: Low incidence of abnormal (18)FDG-PET in children with newonset partial epilepsy: A prospective study. Neurology58: 717–722, 2002.
119.
EngelJHenryTRSwartzBE: Positron emission tomography in frontal lobe epilepsy. Epilepsy and the functional anatomy of the frontal lobe, Eds JasperHHRiggioSGoldman-RakicPS, 223–238. Raven Press, New York1995.
120.
De VolderAGGadisseuxJFMichelCJ: Brain glucose utilization in band heterotopia: Synaptic activity df “double cortex”. Pediatr Neurol11. 290–294, 1994.
121.
BairamianDDi ChiroGTheodoreWH: MR imaging and positron emission tomography of cortical heterotopia. Comp Assis Tomogr9: 1137–1139, 1985.
122.
FalconerJWadaJAMartinWLiD: PET, CT, and MRI imaging of neuronal migration anomalies in epileptic patients. Can J Neurol Sci17: 35–39, 1990.
123.
RichardsonMPKoeppMJBrooksDJ: Cerebral activation in malformations of cortical development. Brain121: 1295–1304, 1998.
124.
MullerRABehenMEMuzikO: Task-related activations in heterotopic brain malformations: A pet study. Neuroreport9: 2527–2533, 1998.
125.
SzeliesBWeber-LuxenburgerGPawlikG: MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy. Neuroimage3: 109–118, 1996.
126.
DebetsRMSadzotBVan IsseltJW: Is 11C-Flumazenil PET Superior to 18FDG PET and 123I-Iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy?J Neurol Neurosurg Psychiatry62: 141–150, 1997.
127.
JuhaszCChuganiDCMuzikO: Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy. Neurology55: 825–835, 2000.
128.
KoeppMJRichardsonMPBrooksDJ: Central benzodiazepine receptors in hippocampal sclerosis: An objective in vivo analysis. Brain119: 1677–1687, 1996.
129.
KoeppMJRichardsonMPLabbeC: 11C-flumazenil PET, volumetric MRI and quantitative pathology in mesial temporal lobe epilepsy. Neurology49: 764–773, 1997.
130.
KoeppMJLabbeCRichardsonMP: Regional hippocampal [11C]-flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. Brain120: 1865–1876, 1997.
131.
HammersAKoeppMJLabbeC: Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy. Neurology56: 897–906, 2001.
132.
HandKSPBairdVHVan PaesschenW: Central benzodiazepine receptor autoradiography in hippocampal sclerosis. Br J Pharmacol122: 358–364, 1997.
133.
KoeppMJHandKSPLabbeC: In Vivo 11C-flumazenil PET correlates with ex vivo 3H-flumazenil autoradiography in hippocampal sclerosis. Ann Neurol43: 618–626, 1998.
134.
RyvlinPBouvardSLe BarsD: Clinical utility of flumazenil-PET versus FDG-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Brain121: 2067–2081, 1998.
135.
RichardsonMPKoeppMJBrooksDJ: Benzodiazepine receptors in focal epilepsy associated with cortical sysgenesis: An 11C-flumazenil PET study. Ann Neurol40: 188–198, 1996.
136.
RichardsonMPFristonKJSisodiyaSM: Benzodiazepine receptors in malformations of cortical development: A voxel-based comparison of structural and functional data: In cortical grey matter. Brain120: 1961–1974, 1997.
137.
HammersAKoeppMJMpRichardson: Central benzodiazepine receptors in malformations of cortical development: A quantitative study. Brain124: 1555–1565, 2001.
138.
RichardsonMPHammersABrooksDJ: Benzodiazepine-GABAA receptor binding is very low in dysembryoplastic neuroepithelial tumor: A PET study. Epilepsia41: 1327–1334, 2001.
139.
LamusuoSPitkänenAJutilaL: [11C]flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy. Correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology. Neurology54: 2252–2260, 2000.
140.
KoeppMJHammersABrooksDJ: 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI. Neurology54: 332–339, 2000.
141.
RyvlinPBouvardSLe BarsD: Transient and falsely lateralizing flumazenil-PET asymmetries in temporal lobe epilepsy. Neurology53: 1882–1885, 1999.
142.
HammersAKoeppMJHurlemannR: Abnormalities of grey and white matter [11C] flumazenil binding in temporal lobe epilepsy with normal MRI. Brain89: 2257–2271, 2002.
RichardsonMPKoeppMJBrooksDJ: 11C-flumazenil PET in neocortical epilepsy. Neurology51: 485–492, 1998.
145.
MuzikODa SilvaEAJuhaszC: Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology54: 171–179, 2000.
146.
HammersAKoeppMJHurlemannR: Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients. Brain126: 1300–1318, 2003.
147.
MaybergHSSadzotBMeltzerCC: Quantification of mu and Nonmu opiate receptors in temporal lobe epilepsy using positron emission tomography. Ann Neurol30: 3–11, 1991.
148.
MadarILesserRPKraussG: Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography. Ann Neurol41: 358–367, 1997.
149.
KoeppMJRichardsonMPBrooksDJDuncanJS: Focal cortical release of endogenous opioids during reading induced seizures. Lancet352: 952–955, 1998.
150.
KumlienEHartvigPValindS: NMDA-receptor activity visualized with (S)-[N-Methyl-11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy. Epilepsia40: 30–37, 1999.
151.
KumlienENilssonAHagbergG: PET with 11C-deuterium-deprenyl and 18F-FDG in focal epilepsy. Acta Neurol Scand103: 360–366, 2001.
152.
ChuganiDCChuganiHTMuzikO: Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography. Ann Neurol44: 858–866, 1998.
153.
FediMReutensDOkazawaH: Localizing value of alphamethyl-L-tryptophan PET in intractable epilepsy of neocortical origin. Neurology57: 1629–1636, 2001.
154.
JuhaszCChuganiDCMuzikO: Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology60: 960–968, 2003.
155.
NatsumeJKumakuraYBernasconiN: Alpha-[11C] methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. Neurology60: 756–761, 2003.
156.
BanatiRBGoerresGWMyersR: [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in rasmussen's encephalitis. Neurology53: 2199–2203, 1999.
157.
GoerresGWReveszTDuncanJS: Imaging cerebral vasculitis in refractory epilepsy using [11C](R) PK11195. Am J Roentgenol176: 1016–1018, 2001.